<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39355148</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2090-6501</ISSN><JournalIssue CitedMedium="Print"><Volume>2024</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Case reports in endocrinology</Title><ISOAbbreviation>Case Rep Endocrinol</ISOAbbreviation></Journal><ArticleTitle>COVID-19-Induced Refractory Symptomatic Hypocalcemia in a Patient With Parathyroid Gland Reimplantation.</ArticleTitle><Pagination><StartPage>6375828</StartPage><MedlinePgn>6375828</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6375828</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2024/6375828</ELocationID><Abstract><AbstractText><b>Background:</b> Several cases of severe hypocalcemia in the setting of COVID-19 have been reported. The proposed mechanisms include direct viral interaction with ACE2 receptors in the parathyroid gland, viral chelation of calcium, worsening hypovitaminosis D, critical illness leading to unbound fatty acids binding calcium, and inflammatory cytokines leading to PTH resistance. Given the life-threatening nature of hypocalcemia, this underrecognized phenomenon should be on the forefront of the clinician's attention. This case highlights a rare manifestation of COVID-19 and further complicated by the patient's reimplanted parathyroid gland. <b>Presentation:</b> A 73-year-old female with primary hyperparathyroidism status post parathyroidectomy with reimplantation in the left forearm presented with 4 days of viral syndrome, found to have tetany and Chvostek's sign on physical exam. Pertinent laboratory abnormalities included calcium 5.3 mg/dL, ionized calcium 0.44 mmol/L, magnesium 1.4 mg/dL, phosphorous 5.5 mg/dL, PTH 242 pg/mL, and 25-OH vitamin D 56 ng/mL. Chest CT revealed multifocal pneumonia consistent with positive COVID-19 testing. She was subsequently admitted to the ICU for severe, symptomatic hypocalcemia and was initiated on a continuous calcium infusion, remdesivir, baricitinib, and steroids. Tetany resolved after 9 g calcium repletion, and she was transferred to the medical floor with an ionized calcium of 0.83 mmol/L. On hospital day 3, repeat ionized calcium was 0.78 mmol/L despite ongoing repletion. Given the persistence of hypocalcemia, a repeat PTH level was obtained which remained high at 487 pg/mL, suggesting ongoing PTH interference in the setting of COVID-19. PTH was obtained from the right (nonimplanted) arm which was normal at 74 pg/mL. This indicated an appropriate PTH response from the reimplanted gland, and that ongoing hypocalcemia may be due to insufficient PTH function to maintain systemic calcium levels or a peripheral interference with PTH level. With continued calcium supplementation and treatment of COVID-19, the patient's calcium stabilized at 8.6 mg/dL. She was discharged on oral calcium supplementation with endocrinology follow-up. <b>Conclusion:</b> Acute hypocalcemia strongly correlates with a profound inflammatory response in COVID-19 patients. This case corroborates the cytokine/PTH hypothesis. This patient had a high PTH sampled near the reimplanted gland but an inappropriately normal PTH from the nonimplanted arm, indicating that direct viral interaction interfering with PTH release is an unlikely mechanism. This case represents a scenario where PTH can be sampled directly from the source and this type of model could aid in the process of determining the etiology of hypocalcemia in COVID-19.</AbstractText><CopyrightInformation>Copyright © 2024 Crystal Tse and Ho-Man Yeung.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Crystal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine Lewis Katz School of Medicine Temple University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Ho-Man</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0002-7188-9738</Identifier><AffiliationInfo><Affiliation>Department of Medicine Lewis Katz School of Medicine Temple University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Case Rep Endocrinol</MedlineTA><NlmUniqueID>101576457</NlmUniqueID><ISSNLinking>2090-651X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">hypocalcemia</Keyword><Keyword MajorTopicYN="N">parathyroid hormone interference</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39355148</ArticleId><ArticleId IdType="pmc">PMC11444793</ArticleId><ArticleId IdType="doi">10.1155/2024/6375828</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>di Filippo L., Allora A., Locatelli M., et al. Hypocalcemia in COVID-19 Is Associated With Low Vitamin D Levels and Impaired Compensatory PTH Response. Endocrine . 2021;74(2):219–225. doi: 10.1007/s12020-021-02882-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02882-z</ArticleId><ArticleId IdType="pmc">PMC8480127</ArticleId><ArticleId IdType="pubmed">34586582</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L., Formenti A. M., Doga M., et al. Hypocalcemia is a Distinctive Biochemical Feature of Hospitalized COVID-19 Patients. Endocrine . 2021;71(1):9–13. doi: 10.1007/s12020-020-02541-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02541-9</ArticleId><ArticleId IdType="pmc">PMC7649576</ArticleId><ArticleId IdType="pubmed">33165763</ArticleId></ArticleIdList></Reference><Reference><Citation>Díez J. J., Iglesias P., García A., Martín-Casasempere I., Bernabéu-Andréu F. A. Serum Calcium, Magnesium, and Phosphorus Levels in Patients With COVID-19: Relationships With Poor Outcome and Mortality. Hormone and Metabolic Research . 2023;55(1):31–39. doi: 10.1055/a-1899-8862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1899-8862</ArticleId><ArticleId IdType="pubmed">35998676</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L., Doga M., Frara S., Giustina A. Hypocalcemia in COVID-19: Prevalence, Clinical Significance and Therapeutic Implications. Reviews in Endocrine and Metabolic Disorders . 2022;23(2):299–308. doi: 10.1007/s11154-021-09655-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09655-z</ArticleId><ArticleId IdType="pmc">PMC8041474</ArticleId><ArticleId IdType="pubmed">33846867</ArticleId></ArticleIdList></Reference><Reference><Citation>Akirov A., Gorshtein A., Shraga-Slutzky I., Shimon I. Calcium Levels on Admission and before Discharge Are Associated with Mortality Risk in Hospitalized Patients. Endocrine . 2017;57(2):344–351. doi: 10.1007/s12020-017-1353-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-017-1353-y</ArticleId><ArticleId IdType="pubmed">28667379</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M., Kim I., Nichol A., et al. Ionized Calcium Concentration and Outcome in Critical Illness. Critical Care Medicine . 2011;39(2):314–321. doi: 10.1097/CCM.0b013e3181ffe23e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181ffe23e</ArticleId><ArticleId IdType="pubmed">21099425</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A. Hypovitaminosis D and the Endocrine Phenotype of COVID-19. Endocrine . 2021;72(1):1–11. doi: 10.1007/s12020-021-02671-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02671-8</ArticleId><ArticleId IdType="pmc">PMC7972333</ArticleId><ArticleId IdType="pubmed">33738708</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L., Formenti A. M., Giustina A. Hypocalcemia: The Quest for the Cause of a Major Biochemical Feature of COVID-19. Endocrine . 2020;70(3):463–464. doi: 10.1007/s12020-020-02525-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02525-9</ArticleId><ArticleId IdType="pmc">PMC7580813</ArticleId><ArticleId IdType="pubmed">33094473</ArticleId></ArticleIdList></Reference><Reference><Citation>Millet J. K., Whittaker G. R. Physiological and Molecular Triggers for SARS-CoV Membrane Fusion and Entry into Host Cells. Virology . 2018;517:3–8. doi: 10.1016/j.virol.2017.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.12.015</ArticleId><ArticleId IdType="pmc">PMC7112017</ArticleId><ArticleId IdType="pubmed">29275820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai A. L., Millet J. K., Daniel S., Freed J. H., Whittaker G. R. The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner. Journal of Molecular Biology . 2017;429(24):3875–3892. doi: 10.1016/j.jmb.2017.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2017.10.017</ArticleId><ArticleId IdType="pmc">PMC5705393</ArticleId><ArticleId IdType="pubmed">29056462</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L., De Lorenzo R., D’Amico M., et al. COVID-19 is Associated With Clinically Significant Weight Loss and Risk of Malnutrition, Independent of Hospitalisation: A Post-Hoc Analysis of a Prospective Cohort Study. Clinical Nutrition . 2021;40(4):2420–2426. doi: 10.1016/j.clnu.2020.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.10.043</ArticleId><ArticleId IdType="pmc">PMC7598735</ArticleId><ArticleId IdType="pubmed">33160700</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh V. P., Khatua B., El-Kurdi B., Rood C. Mechanistic Basis and Therapeutic Relevance of Hypocalcemia During Severe COVID-19 Infection. Endocrine . 2020;70(3):461–462. doi: 10.1007/s12020-020-02530-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02530-y</ArticleId><ArticleId IdType="pmc">PMC7585352</ArticleId><ArticleId IdType="pubmed">33099749</ArticleId></ArticleIdList></Reference><Reference><Citation>Onyema M. C., Kearney J., Dimitriadis G. K. Glucocorticoid-Induced Hypocalcemia in a Patient With Established Hypoparathyroidism. The American Journal of Medicine . 2021;134(5):e321–e322. doi: 10.1016/j.amjmed.2020.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2020.10.040</ArticleId><ArticleId IdType="pubmed">33316255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H., Kang C. K., Im J. H., Cho Y., Kang D. Y., Lee J. Y. Adverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study. Journal of Korean Medical Science . 2023;38(44) doi: 10.3346/jkms.2023.38.e346.e346</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e346</ArticleId><ArticleId IdType="pmc">PMC10643246</ArticleId><ArticleId IdType="pubmed">37967875</ArticleId></ArticleIdList></Reference><Reference><Citation>Puca E., Puca E., Pipero P., Kraja H., Como N. Severe Hypocalcaemia in a COVID-19 Female Patient. Endocrinology, Diabetes &amp; Metabolism Case Reports . 2021;2021(1):20–0097. doi: 10.1530/EDM-20-0097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EDM-20-0097</ArticleId><ArticleId IdType="pmc">PMC7849476</ArticleId><ArticleId IdType="pubmed">33522493</ArticleId></ArticleIdList></Reference><Reference><Citation>Pla B., Silva M., Arranz A., Marazuela M. Severe and Treatment-Resistant Hypocalcemia in Patient With Bilateral COVID-19 Pneumonia. Endocrinología, Diabetes y Nutrición (English ed) . 2021;68(7):518–519. doi: 10.1016/j.endien.2020.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.endien.2020.06.011</ArticleId><ArticleId IdType="pmc">PMC8599090</ArticleId><ArticleId IdType="pubmed">34863419</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez-Ortiz M. E., Rodríguez M. Recent Advances in Understanding and Managing Secondary Hyperparathyroidism in Chronic Kidney Disease. F1000Research . 2020;9 doi: 10.12688/f1000research.1077</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research</ArticleId><ArticleId IdType="pmc">PMC7463297</ArticleId><ArticleId IdType="pubmed">32913635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., He L., Zhang Q., et al. Organ Distribution of Severe Acute Respiratory Syndrome (SARS) Associated Coronavirus (SARS-CoV) in SARS Patients: Implications for Pathogenesis and Virus Transmission Pathways. The Journal of Pathology . 2004;203(2):622–630. doi: 10.1002/path.1560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1560</ArticleId><ArticleId IdType="pmc">PMC7167761</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId></ArticleIdList></Reference><Reference><Citation>He L., Ding Y., Zhang Q., et al. Expression of Elevated Levels of pro-Inflammatory Cytokines in SARS-CoV-Infected ACE2+ Cells in SARS Patients: Relation to the Acute Lung Injury and Pathogenesis of SARS. The Journal of Pathology . 2006;210(3):288–297. doi: 10.1002/path.2067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2067</ArticleId><ArticleId IdType="pmc">PMC7167655</ArticleId><ArticleId IdType="pubmed">17031779</ArticleId></ArticleIdList></Reference><Reference><Citation>Canaff L., Hendy G. N. Calcium-Sensing Receptor Gene Transcription is Up-Regulated by the Proinflammatory Cytokine, Interleukin-1β. Role of the NF-κB PATHWAY and κB elements. The Journal of Biological Chemistry . 2005;280(14):14177–14188. doi: 10.1074/jbc.M408587200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M408587200</ArticleId><ArticleId IdType="pubmed">15684428</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotti G., Lavezzi E., Brunetti A., et al. Humanitas COVID19 Task Force, Vitamin D Deficiency, Secondary Hyperparathyroidism and Respiratory Insufficiency in Hospitalized Patients With COVID-19. Journal of Endocrinological Investigation . 2021;44(10):2285–2293. doi: 10.1007/s40618-021-01535-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01535-2</ArticleId><ArticleId IdType="pmc">PMC7934807</ArticleId><ArticleId IdType="pubmed">33666876</ArticleId></ArticleIdList></Reference><Reference><Citation>Matikainen N., Pekkarinen T., Ryhänen E. M., Schalin-Jäntti C. Physiology of Calcium Homeostasis: An Overview. Endocrinology and Metabolism Clinics of North America . 2021;50(4):575–590. doi: 10.1016/j.ecl.2021.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2021.07.005</ArticleId><ArticleId IdType="pubmed">34774235</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallaro G., Iorio O., Centanni M., et al. Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: A Simple and Effective Way to Avoid Hypoparathyroidism. World Journal of Surgery . 2015;39(8):1936–1942. doi: 10.1007/s00268-015-3070-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-015-3070-0</ArticleId><ArticleId IdType="pubmed">25862025</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>